Regulatory Acceptance of EHR-Derived Data in Pharma Studies
Regulatory Acceptance of EHR-Derived Data in Pharma Studies How Regulatory Bodies Accept EHR-Derived Data in Pharma Studies Electronic Health Records (EHRs) are increasingly used as real-world data (RWD) sources for generating real-world evidence (RWE) in pharmaceutical research. However, not all EHR-derived data is considered fit-for-purpose by global regulatory agencies such as the EMA and the…
Read More “Regulatory Acceptance of EHR-Derived Data in Pharma Studies” »